• Calcitriol: VDR Biology, Evidence, and Research Use

  2026-09-23

  Calcitriol, also called 1,25-dihydroxy vitamin D3, is an active vitamin D metabolite used to investigate vitamin D receptor signaling and cellular biology. Evidence includes VDR-dependent decidualization findings in human endometrial stromal cells, while immune and cancer findings remain model-specific and should not be treated as clinical outcomes.

• WZ4003 Lowers Tau Ser356 in Brain Tissue

  2026-09-23

  Taylor et al. associated tau phosphorylation at Ser356 with Alzheimer’s disease progression and neurofibrillary tangles, then tested the NUAK1/2 inhibitor WZ4003 in mouse and human brain slice cultures. The study found a culture- and species-dependent response, including selective reduction of p-tau Ser356 in live human tissue, while highlighting important limitations for translating ex vivo findings.

• ATRNL1 and Cell States in Atrial Fibrillation

  2026-09-22

  This reference study applies large-scale single-nucleus RNA sequencing to human left atrial tissue and identifies cardiomyocyte- and macrophage-specific transcriptional changes associated with atrial fibrillation. ATRNL1 emerged as an AF-associated cardiomyocyte gene, with functional experiments linking its abundance to cellular stress responses and cardiac action-potential regulation.

• (+)-Bicuculline Protocol and QC Guide

  2026-09-22

  (+)-Bicuculline is a practical GABAA receptor antagonist for controlled studies of inhibitory neurotransmission, GABAergic signaling, and related synaptic NMDA receptor signaling modulation. This guide addresses solvent handling, stock preparation, storage, controls, and interpretation limits; the compound is for research use only and is not intended for diagnostic, clinical, or therapeutic applications.

• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-09-21

  A 2026 FASEB Journal study developed chemically modified p21 mRNA in lipid nanoparticles for localized bladder cancer treatment. Its data connect intravesical delivery with restored nuclear p21, cell-cycle suppression, tumor growth inhibition, and limited systemic distribution, while also defining important preclinical questions for translation.

• IGF2BP1–TUBB4B Axis in Liver Fibrosis

  2026-09-21

  The reference study identifies an m6A-dependent mechanism in which IGF2BP1 stabilizes TUBB4B mRNA, activates FAK signaling, and promotes hepatic stellate cell behavior associated with liver fibrosis. Its integrated sequencing, genetic perturbation, and pharmacological evidence provides a framework for testing RNA stability and methylation mechanisms in fibrogenic cells.

• Tauroursodeoxycholic Acid: Assay Logic

  2026-09-20

  Tauroursodeoxycholic Acid (TUDCA) is most informative when used as a causal probe rather than a generic cytoprotectant. This guide translates ER stress and neuroinflammation findings after subarachnoid hemorrhage into rigorous assay decisions across neurodegenerative disease models, metabolic disorder studies, and regenerative medicine research.

• Potassium Iodide: An Evidence-Gated Research Guide

  2026-09-19

  Potassium Iodide is more than a soluble iodide source: its value depends on matching chemical form, matrix, storage, and biological endpoint. This guide separates established thyroid applications from exploratory immunotherapy connections and translates the distinction into better assay decisions.

• Genotyping the EP4–CD36 Atherosclerosis Axis

  2026-09-18

  Reliable mouse genotyping is more than a colony-management task: it is a prerequisite for assigning mechanistic causality in complex disease models. Using recent evidence on macrophage EP4 deficiency, this thought-leadership article explains how direct, high-fidelity PCR workflows can strengthen studies of CD36-driven lipid uptake, foam-cell formation, macrophage polarization, and atherosclerosis progression.

• Staurosporine and the Kinase Logic of TNBC Metastasis

  2026-09-18

  Staurosporine offers translational researchers a powerful but deliberately nonselective way to test whether kinase activity supports the TBXA2R–Rho–SLK/LOK–ERM signaling axis that drives triple-negative breast cancer motility and metastatic colonization. This thought-leadership guide explains how to use the compound as a mechanistic benchmark, distinguish signaling effects from apoptosis, and avoid overinterpreting broad kinase inhibition as pathway-specific or clinical evidence.

• Bay 11-7085: From NF-κB Probe to Assay Logic

  2026-09-17

  Bay 11-7085 is an NF-κB activation inhibitor that can connect inflammatory signaling to cell-cycle arrest and apoptosis. This guide develops an assay-centered framework for interpreting the probe across ER-stress neuroinflammation, endometriosis, and pneumococcal meningitis research without overstating pathway specificity.

• NIH/3T3 Cells: Culture, QC, and Assay Setup

  2026-09-17

  NIH/3T3 Cells (BC1017) provide a cryopreserved, adherent mouse fibroblast starting material for controlled expansion, cell transfection studies, viral proliferation research, and oncogene research. This guide defines recovery, culture, assay preparation, and QC practices while clarifying that the product dossier does not establish quantitative performance, viral permissiveness, diagnostic utility, or clinical applicability.

• 3-Deazaadenosine Hydrochloride: From SAHH to Fibrosis

  2026-09-16

  A mechanistic and translational framework for using 3-Deazaadenosine hydrochloride to interrogate SAHH-dependent methyl metabolism in hepatic stellate cell models, while distinguishing upstream methylation perturbation from direct m6A-reader or downstream pathway targeting.

• Endothelial SGK1 Mediates Vascular Stiffening

  2026-09-16

  Zhang and colleagues identify endothelial SGK1 as a causal mediator of salt-sensitive endothelial and aortic stiffening, linking mineralocorticoid and sodium signaling to actin remodeling. By combining global and endothelial-specific genetics with human endothelial-cell pharmacology, the study provides a mechanistic rationale for evaluating SGK inhibition in hypertension research while defining important limits for clinical and cross-disease interpretation.

• Aclacinomycin A Workflows for DNA Damage Studies

  2026-09-15

  Build time-resolved assays that connect Aclacinomycin A–induced topological stress with rDNA damage, PML-nucleolar responses, and apoptosis. The workflow separates early DNA-lesion biology from later caspase signaling, proteasome effects, and necrotic collapse.

8054 records 1/537 page Next 12345 下5页 Last page